In 2020, the Chinese film market surpassed North America as the most lucrative in the world, thanks largely to the COVID-19 pandemic, which swept the globe early that year. China’s effective (though controversial) handling of the pandemic insulated its film market from negative effects, while the USA’s disastrous handling crippled its film industry. In 2022, however, the shoe was on the other foot, thanks in part to Doctor Strange 2 and Top Gun: Maverick.

RELATED: One Show Discovered The Multiverse Years Ago (And Did It Better)

Per The Hollywood Reporter, in the first half of this year, China saw a 38% decrease in ticket sales from the same period last year, with only $2.6 billion in revenue. This is due in part to a worsening of COVID woes in China, where strict lockdowns in major population centers like Shanghai and Shenzhen have had brutal financial effects. Meanwhile, the loosening of COVID restrictions in the United States, the increased normalization of movie-going, and the return of major franchises to the screen have led to a substantial recovery of the North American film market. In the first half of this year, North America generated $3.7 billion, almost equal to the entirety of 2021 ticket sales. Part of this story has been the fantastic performance of blockbusters like Top Gun: Maverick (which grossed $571 million domestically so far) and Doctor Strange in the Multiverse of Madness (with $410 million), which both had numbers so colossal they bring one back to the good old days before the viral apocalypse. Although this recovery is great news, there’s still a long way to go: this year’s earnings so far are only 65% of what they were in 2019, before COVID.

The rise of the Chinese market has, up until now, not exactly been the death knell of Hollywood, though. For the past several years, the prospect of the Chinese market has made Hollywood executives’ mouths water. Most US blockbusters are now explicitly designed to play to the Chinese market. Sometimes this means explicit co-productions like The Great Wall (2016), sometimes it means incorporating pro-Chinese sentiment into US films such as The Martian (2015), and sometimes it means submitting films to the Chinese government to make sure it passes censorship standards.

However, since COVID and the weakening of US-China relations, Hollywood films are earning far less in China than they used to. In the first half of 2019, US films made $1.9 billion in China alone. This year, that went down to $400 million, the lowest in nearly a decade. The Chinese film market is becoming more and more self-sufficient, and its revenue is increasingly made by domestic productions. The biggest film in China this year has been the blockbuster war film Battle at Lake Changjin II, which has made $626 million. That’s even more than Top Gun: Maverick has made in the United States, though the latter may yet surpass that.

When you consider the global market, though, Top Gun: Maverick has made far more than Battle at Lake Changjin II. The Chinese market is highly insular, and their films rarely get traction abroad — at least for now. While Hollywood has seen the growth of China primarily as a place to make its own fortunes, this too may be permanently changing. It’s hard to tell what the future holds, but one thing is certain: North America’s place at the top is looking very shaky indeed.

Top Gun: Maverick and Doctor Strange in the Multiverse of Madness are currently in theaters.

MORE: 8 Games To Play If You Enjoyed Top Gun: Maverick

Source: The Hollywood Reporter